{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T07:54:42Z","timestamp":1719129282422},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s12072-014-9586-9","type":"journal-article","created":{"date-parts":[[2014,11,3]],"date-time":"2014-11-03T09:06:04Z","timestamp":1415005564000},"page":"67-75","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prognostic effect of response to interferon therapy after laparoscopic splenectomy among patients with marked thrombocytopenia and hepatitis C virus-related cirrhosis"],"prefix":"10.1007","volume":"9","author":[{"given":"Hideyuki","family":"Tamai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Shingaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyunya","family":"Nuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosaku","family":"Moribata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimasa","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Muraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisanobu","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izumi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Maekita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikitaka","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsunari","family":"Takifuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Yamaue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Ichinose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,1]]},"reference":[{"key":"9586_CR1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","volume":"44","author":"G D\u2019Amico","year":"2006","unstructured":"D\u2019Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006;44:217\u2013231","journal-title":"J Hepatol"},{"key":"9586_CR2","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/hep.23809","volume":"52","author":"PJ Pockros","year":"2010","unstructured":"Pockros PJ, Hamzeh FM, Martin P, Lentz E, Zhou X, Govindarajan S, et al. Histologic outcomes in hepatitis C-infected patients with varying degrees of virologic response to interferon-based treatments. Hepatology 2010;52:1193\u20132200","journal-title":"Hepatology"},{"key":"9586_CR3","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0140-6736(95)91739-X","volume":"346","author":"S Nishiguchi","year":"1995","unstructured":"Nishiguchi S, Kuroki T, Nakatani S, Morimoto H, Takeda T, Nakajima S, et al. Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 1995;346:1051\u20131055","journal-title":"Lancet"},{"key":"9586_CR4","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0140-6736(00)03595-9","volume":"357","author":"S Nishiguchi","year":"2001","unstructured":"Nishiguchi S, Shiomi S, Nakatani S, Takeda T, Fukuda K, Tamori A, et al. Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis. Lancet. 2001;357:196\u2013197","journal-title":"Lancet"},{"key":"9586_CR5","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1056\/NEJMoa073255","volume":"357","author":"JG McHutchison","year":"2007","unstructured":"McHutchison JG, Dusheiko G, Shiffman ML, Rodriguez-Torres M, Sigal S, Bourliere M, et al. Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C. N Engl J Med 2007;357:2227\u20132236","journal-title":"N Engl J Med"},{"issue":"43","key":"9586_CR6","first-page":"1","volume":"2013","author":"Editors of the Drafting Committee for Hepatitis Management Guidelines: The Japan Society of H. Guidelines for the Management of Hepatitis C Virus Infection: First edition","year":"2012","unstructured":"Editors of the Drafting Committee for Hepatitis Management Guidelines: The Japan Society of H. Guidelines for the Management of Hepatitis C Virus Infection: First edition. The Japan Society of Hepatology. Hepatol Res 2012;2013(43):1\u201334","journal-title":"Hepatol Res"},{"key":"9586_CR7","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3748\/wjg.14.176","volume":"14","author":"T Okabayashi","year":"2008","unstructured":"Okabayashi T, Hanazaki K. Overwhelming postsplenectomy infection syndrome in adults\u2013a clinically preventable disease. World J Gastroenterol 2008;14:176\u2013179","journal-title":"World J Gastroenterol"},{"key":"9586_CR8","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1872-034X.2008.00384.x","volume":"38","author":"T Ikegami","year":"2008","unstructured":"Ikegami T, Shimada M, Imura S. Recent role of splenectomy in chronic hepatic disorders. Hepatol Res 2008;38:1159\u20131171","journal-title":"Hepatol Res"},{"key":"9586_CR9","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/s00464-009-0653-6","volume":"24","author":"T Akahoshi","year":"2010","unstructured":"Akahoshi T, Tomikawa M, Korenaga D, Ikejiri K, Saku M, Takenaka K. Laparoscopic splenectomy with peginterferon and ribavirin therapy for patients with hepatitis C virus cirrhosis and hypersplenism. Surg Endosc 2010;24:680\u2013685","journal-title":"Surg Endosc"},{"key":"9586_CR10","first-page":"488","volume":"17","author":"K Ikezawa","year":"2010","unstructured":"Ikezawa K, Naito M, Yumiba T, Iwahashi K, Onishi Y, Kita H, et al. Splenectomy and antiviral treatment for thrombocytopenic patients with chronic hepatitis C virus infection. J Viral Hepat 2010;17:488\u2013492","journal-title":"J Viral Hepat"},{"key":"9586_CR11","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/000313481107700216","volume":"77","author":"Y Shigekawa","year":"2011","unstructured":"Shigekawa Y, Uchiyama K, Takifuji K, Ueno M, Hama T, Hayami S, et al. A laparoscopic splenectomy allows the induction of antiviral therapy for patients with cirrhosis associated with hepatitis C virus. Am Surg 2011;77:174\u2013179","journal-title":"Am Surg"},{"key":"9586_CR12","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/hepr.12184","volume":"44","author":"N Ikeda","year":"2014","unstructured":"Ikeda N, Imanishi H, Aizawa N, Tanaka H, Iwata Y, Enomoto H, et al. Nationwide survey in Japan regarding splenectomy\/partial splenic embolization for interferon treatment targeting hepatitis C virus-related chronic liver disease in patients with low platelet count. Hepatol Res 2014;44:829\u2013836","journal-title":"Hepatol Res"},{"key":"9586_CR13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jhep.2011.02.023","volume":"55","author":"European Association for the Study of the L","year":"2011","unstructured":"European Association for the Study of the L. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol 2011;55:245\u2013264","journal-title":"J Hepatol"},{"key":"9586_CR14","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1872-034X.2010.00688.x","volume":"40","author":"S Imura","year":"2010","unstructured":"Imura S, Shimada M, Utsunomiya T, Morine Y, Ikemoto T, Mori H, et al. Impact of splenectomy in patients with liver cirrhosis: results from 18 patients in a single center experience. Hepatol Res 2010;40:894\u2013900","journal-title":"Hepatol Res"},{"key":"9586_CR15","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1872-034X.2008.00481.x","volume":"39","author":"D Morihara","year":"2009","unstructured":"Morihara D, Kobayashi M, Ikeda K, Kawamura Y, Saneto H, Yatuji H, et al. Effectiveness of combination therapy of splenectomy and long-term interferon in patients with hepatitis C virus-related cirrhosis and thrombocytopenia. Hepatol Res 2009;39:439\u2013447","journal-title":"Hepatol Res"},{"key":"9586_CR16","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.cgh.2009.10.026","volume":"8","author":"AK Singal","year":"2010","unstructured":"Singal AK, Singh A, Jaganmohan S, Guturu P, Mummadi R, Kuo YF, et al. Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis. Clin Gastroenterol Hepatol 2010;8:192\u2013199","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9586_CR17","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1159\/000330549","volume":"80","author":"T Kanda","year":"2011","unstructured":"Kanda T, Imazeki F, Mikami S, Kato K, Shimada N, Yonemitsu Y, et al. Occurrence of hepatocellular carcinoma was not a rare event during and immediately after antiviral treatment in Japanese HCV-positive patients. Oncology 2011;80:366\u2013372","journal-title":"Oncology"},{"key":"9586_CR18","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1440-1746.2011.06870.x","volume":"27","author":"T Akahoshi","year":"2012","unstructured":"Akahoshi T, Tomikawa M, Kawanaka H, Furusyo N, Kinjo N, Tsutsumi N, et al. Laparoscopic splenectomy with interferon therapy in 100 hepatitis-C-virus-cirrhotic patients with hypersplenism and thrombocytopenia. J Gastroenterol Hepatol 2012;27:286\u2013290","journal-title":"J Gastroenterol Hepatol"},{"key":"9586_CR19","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","volume":"41","author":"Y Tanaka","year":"2009","unstructured":"Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, et al. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 2009;41:1105\u20131109","journal-title":"Nat Genet"},{"key":"9586_CR20","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","volume":"461","author":"DL Thomas","year":"2009","unstructured":"Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O\u2019Huigin C, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009;461:798\u2013801","journal-title":"Nature"},{"issue":"Suppl 1","key":"9586_CR21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/liv.12391","volume":"34","author":"V Boccaccio","year":"2014","unstructured":"Boccaccio V, Bruno S. Management of HCV patients with cirrhosis with direct acting antivirals. Liver Int 2014;34(Suppl 1):38\u201345","journal-title":"Liver Int"},{"key":"9586_CR22","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00535-012-0679-8","volume":"48","author":"Y Nagaoki","year":"2013","unstructured":"Nagaoki Y, Aikata H, Kobayashi T, Fukuhara T, Masaki K, Tanaka M, et al. Risk factors for the exacerbation of esophageal varices or portosystemic encephalopathy after sustained virological response with IFN therapy for HCV-related compensated cirrhosis. J Gastroenterol 2013;48:847\u2013855","journal-title":"J Gastroenterol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-014-9586-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-014-9586-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-014-9586-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T16:35:03Z","timestamp":1717518903000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-014-9586-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["9586"],"URL":"https:\/\/doi.org\/10.1007\/s12072-014-9586-9","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,1]]}}}